Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering by tsboiAdmin June 1, 2025 0 What You Ought to Know: – Biotechnology firm kyron.bio introduced the profitable closing of a $6.2M (€5.5M) seed funding spherical ...
PhaseV Closes $50M to Advance AI Clinical Development by tsboiAdmin May 26, 2025 0 What You Ought to Know: – PhaseV, an organization on the forefront of making use of artificial intelligence (AI) and ...
Cycle Time is the New Currency of Drug Development by tsboiAdmin May 23, 2025 0 Raj Indupuri, CEO and Co-Founding father of eClinical Options For years, the life sciences {industry} has been making an attempt to handle ...